Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CAStem cell injection for steroid-refractory acute graft-versus-host disease (Phase II)
CTR20232192Phase 2Active
- Sponsor
- Zehui Chenxing
- Start
- Jan 2024
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of CAStem cells in Acute Graft-Versus-Host Disease (aGvHD), sponsored by Zehui Chenxing. Started Jan 2024; status: active.
02
Drugs
CAStem cells
03
Conditions
Acute Graft-Versus-Host Disease (aGvHD)
Beyond the preview
Go deeper on CTR20232192.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20232192.